Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tauriga Sciences's share price for the quarter that ended in Dec. 2021 was $0.03156. Tauriga Sciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2021 was 299.91 Mil. Therefore, Tauriga Sciences's market cap for the quarter that ended in Dec. 2021 was $9.47 Mil.
Tauriga Sciences's quarterly market cap
declined
from Jun. 2021 ($17.28 Mil) to Sep. 2021 ($11.76 Mil) and
declined
from Sep. 2021 ($11.76 Mil) to Dec. 2021 ($9.47 Mil).
Tauriga Sciences's annual market cap
declined
from Mar. 2019 ($12.94 Mil) to Mar. 2020 ($3.48 Mil) but then
increased
from Mar. 2020 ($3.48 Mil) to Mar. 2021 ($31.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tauriga Sciences's Enterprise Value for Today is $0.00 Mil.
Tauriga Sciences Market Cap Historical Data
The historical data trend for Tauriga Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tauriga Sciences's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Tauriga Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tauriga Sciences's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tauriga Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Tauriga Sciences's Market Cap falls into.
Tauriga Sciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tauriga Sciences's Market Cap for the fiscal year that ended in Mar. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tauriga Sciences (OTCPK:TAUG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tauriga Sciences Market Cap Related Terms
Thank you for viewing the detailed overview of Tauriga Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Tauriga Sciences (Tauriga Sciences) Business Description
Tauriga Sciences Inc is a revenue-generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. The firm has entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD-infused chewing gum product has been branded under Tauri-Gum. The company commenced sales of Peach-Lemon and Black Currant CBG Gum. It operates in two segments: Tauri-gum division consists of all retail, wholesale, and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. Pharma segment includes research and development of the company's FDA IND application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TAUG has been successfully added to your 